THE VERTEX.
Back to home
CULTURE30 June 2026

Melissa Etheridge Convenes R.I.S.E. Summit to Reimagine Psychedelic Therapies for Addiction

Melissa Etheridge will host the inaugural R.I.S.E. Summit in Irvine on November 12, featuring a headline fireside chat with Dr. Gabor Maté to discuss emerging psychedelic therapies for addiction. The event reflects a broader cultural shift toward integrating scientific research into addiction treatment.

La
La Rédaction
The Vertex
5 min read
Melissa Etheridge Convenes R.I.S.E. Summit to Reimagine Psychedelic Therapies for Addiction
Source: www.billboard.com
On November 12, 2026, the coastal city of Irvine, California, will host the inaugural R.I.S.E. Summit, a pioneering gathering convened by rock musician Melissa Etheridge to explore novel psychedelic approaches for treating addiction. The summit’s headline session features a fireside conversation between Etheridge and renowned addiction specialist Dr. Gabor Maté, signaling a convergence of art, science, and advocacy, and marking the first large‑scale forum dedicated specifically to psychedelic therapies for substance use disorders. Recent clinical trials have demonstrated that psilocybin‑assisted therapy can reduce relapse rates by up to 50% in alcohol use disorder, while MDMA‑enhanced sessions show promise for opioid dependence. By bringing this evidence into the public arena, Etheridge leverages her platform to destigmatize psychedelic therapy, encouraging policymakers and healthcare providers to reconsider existing regulatory frameworks and insurance coverage models. The R.I.S.E. Summit arrives amid a broader cultural renaissance of psychedelic science, marked by recent FDA breakthrough designations for psilocybin‑assisted therapy and the decriminalization initiatives in several U.S. states and Canadian provinces. Historically, the 1960s counterculture introduced these compounds, but contemporary discourse is anchored in rigorous clinical trials, ethical frameworks, and a pragmatic view of integration rather than rebellion, reflecting a shift from fringe experimentation to mainstream medical acceptance. If the summit successfully translates dialogue into pilot programs, it could accelerate the medicalization of psychedelics, offering a new therapeutic avenue for millions affected by addiction. Yet scaling these interventions will require addressing regulatory hurdles, ensuring equitable access, and integrating peer‑support structures, all of which will shape the future landscape of addiction recovery in the 21st century.